Can Biosimilars Compete With ‘Unbranded Biologics’ In The US Market?

 
• By Derrick Gingery
  
Insulin vials with synringe
Two sponsors already are marketing insulin products as 'unbranded biologics.' • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics